Alkermes plc. Other Noncash Income
Alkermes plc. (ALKS) reported Other Noncash Income of $580.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2022-02-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncome · last filed 2022-02-16
- Alkermes plc. other noncash income for the quarter ending 2018-03-31 was $75.00K.
- Alkermes plc. other noncash income for the quarter ending 2015-12-31 was $831.00K.
- Alkermes plc. other noncash income for fiscal 2019 was $580.00K.
- Alkermes plc. other noncash income for fiscal 2015 was $1.35M.
| Period end | Other Noncash Income 3 month | Other Noncash Income 9 month | Other Noncash Income 12 month |
|---|---|---|---|
| 2019-12-31 | $580.00K 10-K · filed 2022-02-16 | ||
| 2018-03-31 | $75.00K 10-Q · filed 2019-04-25 | ||
| 2015-12-31 | $831.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $1.35M 10-K · filed 2018-02-16 | |
| 2015-09-30 | $520.00K 10-Q · filed 2016-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |